Literature DB >> 26160730

Corticosteroids for paediatric ARDS: unjustified—even unjustifiable?

Mark J Peters1, Samiran Ray, Martin Kneyber.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26160730     DOI： 10.1007/s00134-015-3963-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  10 in total

1.  What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.

Authors:  S Bailly; R Pirracchio; J F Timsit
Journal:  Intensive Care Med       Date:  2015-06-24       Impact factor: 17.440

2.  Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference.

Authors:  Robert F Tamburro; Martin C J Kneyber
Journal:  Pediatr Crit Care Med       Date:  2015-06       Impact factor: 3.624

3.  How to manage ventilation in pediatric acute respiratory distress syndrome?

Authors:  Martin C J Kneyber; Philippe A Jouvet; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

4.  Acute lung injury in children: therapeutic practice and feasibility of international clinical trials.

Authors:  Miriam Santschi; Philippe Jouvet; Francis Leclerc; France Gauvin; Christopher J L Newth; Christopher L Carroll; Heidi Flori; Robert C Tasker; Peter C Rimensberger; Adrienne G Randolph
Journal:  Pediatr Crit Care Med       Date:  2010-11       Impact factor: 3.624

5.  Corticosteroid exposure in pediatric acute respiratory distress syndrome.

Authors:  Nadir Yehya; Sabah Servaes; Neal J Thomas; Vinay M Nadkarni; Vijay Srinivasan
Journal:  Intensive Care Med       Date:  2015-07-10       Impact factor: 17.440

Review 6.  Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Benjamin M P Tang; Jonathan C Craig; Guy D Eslick; Ian Seppelt; Anthony S McLean
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

7.  The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus.

Authors:  Daniele De Luca; Marco Piastra; Giovanna Chidini; Pierre Tissieres; Edoardo Calderini; Sandrine Essouri; Alberto Medina Villanueva; Ana Vivanco Allende; Marti Pons-Odena; Luis Perez-Baena; Michael Hermon; Ascanio Tridente; Giorgio Conti; Massimo Antonelli; Martin Kneyber
Journal:  Intensive Care Med       Date:  2013-10-08       Impact factor: 17.440

Review 8.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.

Authors:  John Victor Peter; Preeta John; Petra L Graham; John L Moran; Ige Abraham George; Andrew Bersten
Journal:  BMJ       Date:  2008-04-23

9.  Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*.

Authors:  Miriam Santschi; Adrienne G Randolph; Peter C Rimensberger; Philippe Jouvet
Journal:  Pediatr Crit Care Med       Date:  2013-09       Impact factor: 3.624

10.  Acute hypoxemic respiratory failure in children: case mix and the utility of respiratory severity indices.

Authors:  M J Peters; R C Tasker; K M Kiff; R Yates; D J Hatch
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440
  10 in total
  3 in total

1.  Focus on paediatrics.

Authors:  Mark J Peters; Warwick Butt; Robert C Tasker
Journal:  Intensive Care Med       Date:  2016-06-02       Impact factor: 17.440

2.  Corticosteroids in pediatric ARDS: all cards on the table.

Authors:  Andreas Schwingshackl; Gianfranco Umberto Meduri; Dai Kimura; Stephania A Cormier; Kanwaljeet J S Anand
Journal:  Intensive Care Med       Date:  2015-09-10       Impact factor: 17.440

3.  Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome.

Authors:  Rebecca B Mitting; Samiran Ray; Michael Raffles; Helen Egan; Paul Goley; Mark Peters; Simon Nadel
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.